In the combined TCGA cohort, the authors reported that patients with a TET1 mutation had a higher TMB, as observed in our study, as well as an increased neoantigen pool and an inflamed pattern of tumor-infiltrating immune signatures41. Here, TET1 is linked to neoplasm.